Hospital-acquired Infection Control Market - Global Forecasts and Drivers by Technavio

Technavio has published a new report on the global hospital-acquired infection control market from 2017-2021. (Graphic: Business Wire)

???pagination.previous??? ???pagination.next???

LONDON--()--Technavio analysts forecast the global hospital-acquired infection control market to grow at a CAGR of almost 5% during the forecast period, according to their latest report.

The research study covers the present scenario and growth prospects of the global hospital-acquired infection control market for 2017-2021. The market is segmented on infection type (CAUTIs, SSIs, CLABSIs, and respiratory infections), end-user (hospitals and ICUs, outpatient care centers, and LTCFs), and geography (the Americas, EMEA, and APAC).

The global HAI control market will grow moderately during the forecast period. This will be due to the growing importance given to prevent or diagnose and treat HAIs. The prevalence of HAIs is increasing at alarming rates across the globe, which is increasing the cost burden of healthcare. It also requires the development of effective preventive strategies by healthcare facilities, which has resulted in several biotechnology companies developing systems that accurately diagnose HAIs. Pharmaceutical companies are also developing specific therapies to cure HAIs.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

Technavio research analysts highlight the following three factors that are contributing to the growth of the global hospital-acquired infection control market:

  • Growth of aging population
  • Increasing innovative measures to prevent HAIs
  • Data analytics contributing to improvements in healthcare facilities

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Growth of aging population

Multiple research studies across the world have highlighted the effects of nosocomial infections on the aging population. The incidence of hospital-acquired UTI, infected surgical wounds, and nosocomial pneumonia is the highest among people above the age of 65. Additionally, studies conducted by the CDC in 2016 have indicated that people above the age of 65 accounted for more than 50% of all nosocomial infections in the US. In Australia, the incidence of hospital-acquired infections such as UTIs was high among elderly people suffering from dementia.

Amber Chourasia, a lead lab equipment research analyst at Technavio, says, “The aging population is vulnerable toward HAIs, so the treatment strategies focused on this population will drive the growth of the global HAI control market. Additionally, since the number of people above the age of 65 is increasing globally, they are the biggest target population for vendors in the global HAI control market.”

Increasing innovative measures to prevent HAIs

Innovative immunization methods are also being adopted by healthcare facilities to prevent the spreading of infections. Researchers in Canada have developed a mobile phone application, ImmunizeCA, which will prevent the spreading of infections. The application can scan and track an individual’s immunization records and store them for further use. These features will help reduce the spreading of infections in Canada.

“Innovative immunization methods are changing the landscape of HAI management and routine hospital activities, which is driving the growth of the market. Furthermore, these innovations are being backed by industry experts and global conferences such as the World Congress on Infection Prevention and Control, International Conference on Prevention & Infection Control, and the Association for Professionals in Infection Control and Epidemiology.,” adds Amber.

Data analytics contributing to improvements in healthcare facilities

Data analytics refers to the collection of tools and techniques that are used to generate insights and take actions based on retrospective or real-time data. Since the last two decades, healthcare systems have been collecting data through electronic medical records (EMRs) and electronic health records (EHRs). When the data is analyzed using various data analytics techniques, it could reveal valuable conclusions and deductions that can be used to improve healthcare settings and even reduce the prevalence of HAIs.

Several information technology companies are employing various algorithms to arrive at inferences that could help improve HAI control. Government organizations also use data analytics to improve their measures to tackle HAIs. For instance, in 2015, the CDC used data analytics to reveal that CDI caused approximately 15,000 deaths and half a million infections each year.

Top vendors:

  • AstraZeneca
  • GlaxoSmithKline
  • Merck
  • Pfizer

Browse Related Reports:

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

Technavio analysts forecast the global hospital-acquired infection control market to grow at a CAGR of almost 5% from 2017-2021.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com